Home - Products - Others - Other Targets - Hypoletin-7-O-β-D-xylopyranoside

Hypoletin-7-O-β-D-xylopyranoside

CAS No. 126771-28-6

Hypoletin-7-O-β-D-xylopyranoside( ——— )

Catalog No. M38510 CAS No. 126771-28-6

Hypoletin-7-O-β-D-xylopyranoside is a natural compound with antioxidant activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Hypoletin-7-O-β-D-xylopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Hypoletin-7-O-β-D-xylopyranoside is a natural compound with antioxidant activity.
  • Description
    Hypoletin-7-O-β-D-xylopyranoside is a natural compound with antioxidant activity.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    126771-28-6
  • Formula Weight
    434.35
  • Molecular Formula
    C20H18O11
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Eun Ha Lee, Flavonoids from the leaves of Thuja orientalis inhibit the aldose reductase and the formation of advanced glycation endproducts. Journal of the Korean Society for Applied Biological Chemistry volume 52, pages448–455 (2009).
molnova catalog
related products
  • KYP-2047

    KYP-2047 is a very potent, selective Prolyl oligopeptidase (POP) inhibitor.In cell lines, oxidative stress induced a robust aggregation of α-synuclein,and low concentrations of KYP-2047 significantly reduced the number of cells with α-synuclein inclusions while abolishing the colocalization of α-synuclein and PREP.

  • Fibrinogen-Binding P...

    Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen, a soluble plasma protein, is a cofactor in platelet activation. It is converted to fibrin in a reaction catalyzed by thrombin.

  • RLX-33

    RLX-33 is a potent and selective antagonist of relaxin family peptide 3 (RXFP3) that crosses the blood-brain barrier and also blocks relaxin 3-induced ERK1/2 phosphorylation.